Innate Pharma SA Sustainability Reports
Innate Pharma S.A. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer patients. The company designs therapeutic antibodies that harness the innate immune system to combat tumors.
Sector: Professional & technical services
Country: France
Exchange: Euronext Paris
LEI: 9695002Y8420ZB8HJE29
FIGI: BBG001SRVGT6
21 reports from 2011 to 2025
